Axxcess Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,631
Closed -$720K 1090
2025
Q3
$720K Sell
2,631
-1,006
-28% -$275K 0.02% 530
2025
Q2
$938K Buy
3,637
+59
+2% +$14.1K 0.02% 441
2025
Q1
$801K Sell
3,578
-6,391
-64% -$1.49M 0.02% 446
2024
Q4
$2.28M Buy
9,969
+3,853
+63% +$928K 0.05% 246
2024
Q3
$1.49M Sell
6,116
-879
-13% -$196K 0.04% 321
2024
Q2
$1.34M Sell
6,995
-867
-11% -$176K 0.04% 328
2024
Q1
$1.56M Sell
7,862
-5,209
-40% -$954K 0.04% 294
2023
Q4
$2.25M Buy
13,071
+832
+7% +$128K 0.07% 231
2023
Q3
$1.81M Buy
+12,239
New +$2.21M 0.06% 221

Other funds holding RMD

Axxcess Wealth Management's RMD Position: Q4 2025 in Review

Axxcess Wealth Management sold out of ResMed (RMD) in Q4 2025, closing a stake of 2,631 shares — an estimated $720K sold.

Axxcess Wealth Management first reported a position in RMD in Q3 2023 and held it in 9 quarters. The position peaked at $2.28M in Q4 2024. 946 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Axxcess Wealth Management reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Axxcess Wealth Management sold 2,631 ResMed shares in Q4 2025, an estimated $720K.
  • Axxcess Wealth Management first reported a position in ResMed in Q3 2023 and held it in 9 quarters.
  • Axxcess Wealth Management's ResMed position peaked at $2.28M in Q4 2024.
  • 946 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Axxcess Wealth Management's 13F filing for Q4 2025, filed 6 Feb 2026.